Cleared Traditional

K102668 - ETEST TOBRAMYCIN 0.016-256 UG/ML AND 0.064-1024 UG/ML (FDA 510(k) Clearance)

Nov 2010
Decision
62d
Days
Class 2
Risk

K102668 is an FDA 510(k) clearance for the ETEST TOBRAMYCIN 0.016-256 UG/ML AND 0.064-1024 UG/ML. This device is classified as a Manual Antimicrobial Susceptibility Test Systems (Class II - Special Controls, product code JWY).

Submitted by BIOMERIEUX (Craponne, FR). The FDA issued a Cleared decision on November 17, 2010, 62 days after receiving the submission on September 16, 2010.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.1640.

Submission Details

510(k) Number K102668 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 16, 2010
Decision Date November 17, 2010
Days to Decision 62 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code JWY - Manual Antimicrobial Susceptibility Test Systems
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.1640

Similar Devices - JWY Manual Antimicrobial Susceptibility Test Systems

All 28
MTS Aztreonam-Avibactam 0.016/4 - 256/4 µg/mL
K252114 · Liofilchem S. R. L. · Oct 2025
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Colistin in the dilution range of 0.12-16 ug/mL
K252062 · Thermo Fisher Scientific · Sep 2025
The Sensititre 18 - 24 hour MIC or Breakpoint Susceptibility System with Aztreonam/avibactam in the dilution range of 0.008/4 - 64/4 ug/mL
K250575 · Thermo Fisher Scientific · Sep 2025
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Amikacin in the dilution range of 0.25-256 ug/mL
K252014 · Thermo Fisher Scientific · Aug 2025
MTS Sulbactam-Durlobactam 0.004/4 - 64/4 µg/mL (SUD)
K251580 · Liofilchem S. R. L. · Aug 2025
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ciprofloxacin in the dilution range of 0.002-64 ug/mL
K250990 · Thermo Fisher Scientific · Jun 2025